Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$209.01 - $232.56 $333,997 - $371,630
1,598 New
1,598 $349,000
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $173,908 - $191,770
865 New
865 $173,000
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $165,962 - $200,591
-778 Reduced 95.23%
39 $8,000
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $123,454 - $150,875
-606 Reduced 42.59%
817 $192,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $22,529 - $28,840
-110 Reduced 7.18%
1,423 $290,000
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $19,461 - $25,286
-91 Reduced 5.6%
1,533 $359,000
Q1 2022

May 10, 2022

BUY
$259.82 - $298.18 $167,324 - $192,027
644 Added 65.71%
1,624 $428,000
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $24,987 - $28,907
92 Added 10.36%
980 $308,000
Q3 2021

Nov 08, 2021

BUY
$274.82 - $308.34 $40,123 - $45,017
146 Added 19.68%
888 $250,000
Q2 2021

Aug 09, 2021

BUY
$251.87 - $278.14 $45,588 - $50,343
181 Added 32.26%
742 $205,000
Q1 2021

Apr 28, 2021

BUY
$204.88 - $255.03 $34,214 - $42,590
167 Added 42.39%
561 $143,000
Q4 2020

Feb 09, 2021

BUY
$186.91 - $214.42 $11,775 - $13,508
63 Added 19.03%
394 $80,000
Q3 2020

Nov 02, 2020

BUY
$167.03 - $201.3 $11,358 - $13,688
68 Added 25.86%
331 $62,000
Q2 2020

Aug 11, 2020

BUY
$113.31 - $182.44 $11,104 - $17,879
98 Added 59.39%
263 $44,000
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $2,190 - $4,100
21 Added 14.58%
165 $21,000
Q4 2019

Feb 13, 2020

SELL
$163.48 - $173.61 $2,125 - $2,256
-13 Reduced 8.28%
144 $24,000
Q3 2019

Oct 17, 2019

SELL
$159.77 - $178.1 $5,112 - $5,699
-32 Reduced 16.93%
157 $26,000
Q2 2019

Aug 05, 2019

BUY
$144.16 - $172.9 $27,246 - $32,678
189 New
189 $33,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.